skip to content
Detailed Quote
5i Report
Rating
B+

Review of Vitalhub Corp.

SEP 11, 2025 - VHI’s track record of compounding capital at a high rate as an acquisitive company is still early but quite solid. We think that if the company manages to execute its acquisitive growth playbook consistently. VHI can continue to grow revenue and earnings in the double-digit range for many years. We think the company is currently trading at a fair valuation; we would be comfortable holding it for the long term. However, as prospective shareholders, we would not be too aggressive in adding to the position at the current price; we are upgrading our rating to B+.

Download Report
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
Q: I hold all three in an RESP that has to be wrapped up in 2026 so will be making larger than usual withdrawals. In what order would you sell and would you buyback in other accounts.
Read Answer Asked by Brendon on October 29, 2025
Insiders
Share Information
News and Media